Stockscreener 앱 받기
1.98%
시간 외 거래:
전일 마감가:
$181.35
열려 있는:
$180.74
하루 거래량:
2.69M
Relative Volume:
0.60
시가총액:
$125.81B
수익:
$24.78B
순이익/손실:
$3.68B
주가수익비율:
34.35
EPS:
5.1743
순현금흐름:
$5.29B
1주 성능:
-3.20%
1개월 성능:
+9.79%
6개월 성능:
-20.15%
1년 성능:
-9.19%
1일 변동 폭
$176.60
$182.42
1주일 범위
$176.60
$184.13
52주 변동 폭
$160.93
$242.80
다나허 Stock (DHR) Company Profile
명칭
Danaher Corp
전화
(202) 828-0850
주소
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
177.76 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
461.69 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
546.09 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
124.33 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
357.00 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
다나허 Stock (DHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 다운그레이드 | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-03-14 | 업그레이드 | Stifel | Hold → Buy |
| 2025-02-03 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-31 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 개시 | HSBC Securities | Hold |
| 2023-12-13 | 재개 | Wolfe Research | Peer Perform |
| 2023-12-07 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-01 | 개시 | SVB Securities | Outperform |
| 2023-04-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-10-24 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-08-17 | 재개 | Bernstein | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-06-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 개시 | Bernstein | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-10 | 재확인 | BofA Securities | Buy |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 재확인 | Goldman | Buy |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-04-07 | 재개 | Robert W. Baird | Outperform |
| 2021-03-03 | 재개 | Barclays | Overweight |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 재개 | Stifel | Hold |
| 2019-10-28 | 재확인 | Needham | Buy |
| 2019-10-14 | 재개 | Credit Suisse | Outperform |
| 2019-07-19 | 재확인 | Needham | Buy |
| 2019-06-11 | 개시 | Piper Jaffray | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-04-17 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2019-02-25 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-04-20 | 재확인 | Stifel | Buy |
모두보기
다나허 주식(DHR)의 최신 뉴스
Danaher’s Cepheid Ebola Tests Highlight Diagnostics Role In Global Crises - Yahoo Finance
Masimo CEO stepping down following acquisition by Danaher - Modern Healthcare
Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations - Yahoo Finance UK
Piper Sandler Begins Coverage of Danaher (DHR) While Waiting for New Growth Catalysts - Insider Monkey
Danaher Corp. Stock (US2358511028): Diagnostics expansion keeps diversified healthcare group in focu - AD HOC NEWS
Danaher boosts product portfolio with the acquisition of Masimo - MSN
Danaher Deepens Diagnostics Reach As Masimo Deal Reshapes Healthcare Focus - Yahoo Finance
Danaher completes acquisition of Masimo, company delists from Nasdaq By Investing.com - Investing.com Nigeria
Danaher Corp. Stock (US2358511028): shares in focus after quiet trading week - AD HOC NEWS
Is Danaher stock underperforming the S&P 500? - MSN
Danaher Masimo Deal Strengthens S&P 500 Healthcare Growth Story - Kalkine Media
Masimo (MASI) director equity cashed out at $180 per share in Danaher merger - Stock Titan
Masimo (MASI) EVP equity cashed out and converted in Danaher merger - Stock Titan
Masimo (MASI) CCO reports merger-driven cancellation and conversion of equity awards - Stock Titan
Masimo (MASI) CHRO equity canceled, cashed out and rolled into Danaher - Stock Titan
Masimo (MASI) GC reports RSU disposals as Danaher merger converts awards - Stock Titan
Masimo (MASI) CMO disposes RSUs, options as Danaher merger closes - Stock Titan
Masimo (MASI) CFO exits company stock as Danaher cash merger closes - Stock Titan
Masimo (MASI) CEO awards canceled, paid $180 per share in Danaher deal - Stock Titan
Deals tracker: Medtronic buys Scientia Vascular for $550M - Modern Healthcare
3 Reasons to Avoid DHR and 1 Stock to Buy Instead - Yahoo Finance
Danaher Boosts Product Portfolio With the Acquisition of Masimo - TradingView
Implied Volatility Surging for Danaher Stock Options - Yahoo Finance UK
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
DHR Initiated Coverage On by Piper Sandler -- Price Target Annou - GuruFocus
1 Unstoppable Healthcare Cash Cow to Buy Hand Over Fist and Hold for 25 Years - Yahoo Finance
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Strong Performance Continues at DHR's Biotechnology Unit: What's Next? - Yahoo Finance
Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)? - Yahoo Finance
Danaher Closes $9.9B Acquisition of Masimo - Medical Product Outsourcing
Piper Sandler initiates Danaher stock coverage with neutral rating By Investing.com - Investing.com Canada
Piper Sandler initiates Danaher stock coverage with neutral rating - Investing.com
Danaher closes $9.9B Masimo buyout - Yahoo Finance
Why Is Danaher Drawing Attention Among Bluestock Indices Trends? - Kalkine Media
Danaher Closes on Acquisition of Masimo - Orange County Business Journal
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher completes acquisition of Masimo, company delists from Nasdaq - Investing.com UK
Danaher (DHR) Completes Acquisition of Masimo, Expanding Diagnos - GuruFocus
Danaher Completes Acquisition of Masimo, Expanding Acute Care Diagnostics Platform - citybiz
Danaher completes $10B acquisition of Masimo - MassDevice
Masimo Pays Off and Terminates 2025 Credit Agreement as Danaher Merger Closes - TradingView
Danaher acquires Masimo (MASI) in all-cash $180-per-share takeover and delisting - Stock Titan
Danaher completes acquisition of Masimo Corporation - Investing.com
Danaher completes acquisition of Masimo Corporation By Investing.com - Investing.com Canada
Danaher Completes Acquisition of Masimo Corporation - Yahoo Finance
Danaher Corporation $DHR Shares Sold by Motley Fool Wealth Management LLC - MarketBeat
Danaher Corporation $DHR Shares Acquired by Cerity Partners LLC - MarketBeat
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Wolfe Research Downgrades Danaher Corporation (DHR) - Insider Monkey
Clearbridge Investments LLC Trims Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Moves Towards Acquisition of Masimo (MASI) - GuruFocus
다나허 (DHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.31%
2.88%
자본화:
|
볼륨(24시간):